Oric Pharmaceuticals Incis A Clinical Stage Biopharmaceutical Company Based In South San Franciscocawith Additional Operations In San Diegocathe Company Is Focused On Improving Patientslives By Developing Therapies That Address Cancer Resistanceits Mission Is Reflected In Its Nameovercoming Resistance In Canceroric Pharmaceuticals Has A Strong Pipeline Of Therapeutic Candidates Targeting Various Cancerscurrentlyit Is Enrolling Patients In Three Phase 1 Studiesoric 533 For Multiple Myelomaoric 114 For Egfr Her2 Cancersand Oric 944 For Prostate Cancerthe Company Collaborates With Strategic Partners To Enhance Its Clinical Trials And Improve Treatment Outcomeswith A Leadership Team Experienced In Oncology Therapeuticsoric Pharmaceuticals Is Committed To Advancing Innovative Solutions In Cancer Treatment
No conferences found for this company.
| Company Name | Oric Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
